[PHARMA] QoQ Annualized Quarter Result on 30-Sep-2022 [#3]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
24-Nov-2022
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2022
Quarter
30-Sep-2022 [#3]
Profit Trend
QoQ- -13.15%
YoY- -57.23%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
Annualized Quarter Result
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
Revenue 3,458,376 3,521,816 3,510,677 3,530,609 3,446,552 3,848,696 4,815,015 -19.84%
PBT 31,070 36,772 -580,846 76,732 83,920 149,756 277,075 -76.83%
Tax -20,890 -25,708 -24,204 -24,536 -24,380 -34,332 -104,870 -65.99%
NP 10,180 11,064 -605,050 52,196 59,540 115,424 172,205 -84.90%
-
NP to SH 9,216 10,592 -607,317 49,430 56,912 110,936 172,150 -85.87%
-
Tax Rate 67.24% 69.91% - 31.98% 29.05% 22.93% 37.85% -
Total Cost 3,448,196 3,510,752 4,115,727 3,478,413 3,387,012 3,733,272 4,642,810 -18.03%
-
Net Worth -137,571 -142,812 -248,894 411,327 406,087 413,947 450,411 -
Dividend
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
Div - - 24,889 33,185 34,058 41,918 121,768 -
Div Payout % - - 0.00% 67.14% 59.84% 37.79% 70.73% -
Equity
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
Net Worth -137,571 -142,812 -248,894 411,327 406,087 413,947 450,411 -
NOSH 1,310,208 1,310,208 1,309,126 1,309,126 1,309,126 1,309,126 1,309,126 0.05%
Ratio Analysis
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
NP Margin 0.29% 0.31% -17.23% 1.48% 1.73% 3.00% 3.58% -
ROE 0.00% 0.00% 0.00% 12.02% 14.01% 26.80% 38.22% -
Per Share
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
RPS 263.96 268.80 268.00 269.52 263.10 293.80 367.74 -19.88%
EPS 0.70 0.80 -46.36 3.77 4.34 8.48 13.15 -85.92%
DPS 0.00 0.00 1.90 2.53 2.60 3.20 9.30 -
NAPS -0.105 -0.109 -0.19 0.314 0.31 0.316 0.344 -
Adjusted Per Share Value based on latest NOSH - 1,309,126
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
RPS 239.96 244.36 243.59 244.97 239.14 267.04 334.09 -19.84%
EPS 0.64 0.73 -42.14 3.43 3.95 7.70 11.94 -85.85%
DPS 0.00 0.00 1.73 2.30 2.36 2.91 8.45 -
NAPS -0.0955 -0.0991 -0.1727 0.2854 0.2818 0.2872 0.3125 -
Price Multiplier on Financial Quarter End Date
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
Date 30/06/23 31/03/23 30/12/22 30/09/22 30/06/22 31/03/22 31/12/21 -
Price 0.37 0.285 0.545 0.515 0.595 0.755 0.74 -
P/RPS 0.14 0.11 0.20 0.19 0.23 0.26 0.20 -21.21%
P/EPS 52.60 35.25 -1.18 13.65 13.70 8.92 5.63 345.41%
EY 1.90 2.84 -85.07 7.33 7.30 11.22 17.77 -77.56%
DY 0.00 0.00 3.49 4.92 4.37 4.24 12.57 -
P/NAPS 0.00 0.00 0.00 1.64 1.92 2.39 2.15 -
Price Multiplier on Announcement Date
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
Date 11/08/23 18/05/23 27/02/23 24/11/22 19/08/22 20/05/22 17/02/22 -
Price 0.42 0.38 0.44 0.55 0.595 0.72 0.76 -
P/RPS 0.16 0.14 0.16 0.20 0.23 0.25 0.21 -16.62%
P/EPS 59.71 47.01 -0.95 14.58 13.70 8.50 5.78 376.36%
EY 1.67 2.13 -105.37 6.86 7.30 11.76 17.30 -79.04%
DY 0.00 0.00 4.32 4.61 4.37 4.44 12.24 -
P/NAPS 0.00 0.00 0.00 1.75 1.92 2.28 2.21 -

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment